Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Comprehensive LC-QTOF-MS Metabolic Phenotyping Strategy: Application to Alkaptonuria.

Norman BP, Davison AS, Ross GA, Milan AM, Hughes AT, Sutherland H, Jarvis JC, Roberts NB, Gallagher JA, Ranganath LR.

Clin Chem. 2019 Apr;65(4):530-539. doi: 10.1373/clinchem.2018.295345. Epub 2019 Feb 19.

PMID:
30782595
2.

Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone.

Davison AS, Harrold JA, Hughes G, Norman BP, Devine J, Usher J, Hughes AT, Khedr M, Gallagher JA, Milan AM, J C G H, Ranganath LR.

Mol Genet Metab. 2018 Sep;125(1-2):135-143. doi: 10.1016/j.ymgme.2018.07.008. Epub 2018 Jul 19.

PMID:
30049652
3.

Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone.

Davison AS, Norman BP, Smith EA, Devine J, Usher J, Hughes AT, Khedr M, Milan AM, Gallagher JA, Ranganath LR.

JIMD Rep. 2018;41:109-117. doi: 10.1007/8904_2018_109. Epub 2018 May 13.

4.

Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.

Norman BP, Lubbe SJ, Tan M, Warren N, Morris HR.

BMC Neurol. 2017 Aug 8;17(1):153. doi: 10.1186/s12883-017-0933-z.

5.

A medical audit and patient survey of hysterectomies performed for menstrual disorders.

Roberts RN, Norman BP, Harrison CG, Heaton NR, Law JK, Wadehra V, Younger HM, West CP.

Scott Med J. 1996 Apr;41(2):44-6.

PMID:
8735501

Supplemental Content

Loading ...
Support Center